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ABSTRACT Inhibition of eicosanoid formation in larvae
of the tobacco hornworm Manduca sexta, using specific inhib-
itors of phospholipase A2, cyclooxygenase, and lipoxygenase,
severely weakened the ability of larvae to clear the bacterium
Serratia marcescens from their hemolymph. The reduced ca-
pability to remove bacteria is associated with increased mor-
tality due to these bacteria. There is a dose-dependent rela-
tionship between the phospholipase A2 inhibitor dexametha-
sone and both the reduced bacterial clearance and increased
larval mortality. The dexamethasone effects on larval survival
were reversed by treatment with arachidonic acid. Maleic acid,
a nonspecific antioxidant, did not interfere with the insects'
ability to remove bacterial cells from hemolymph. The larvae
were shown to contain all of the C20 polyunsaturated fatty acids
necessary for eicosanoid biosynthesis and to be capable of
converting radioactive arachidonic acid into several primary
prostaglandins. These results strongly suggest that eicosanoids
mediate transduction of bacterial infection signals into the
complex of cellular and humoral responses that comprise
invertebrate immunity.
Invertebrate immunity is an amalgam of several distinct
systems, both cellular and humoral, that operate in a more or
less coordinated way to provide protection from invading
pathogens (1). Cellular responses include phagocytosis, en-
capsulation, and various cytotoxic reactions such as release
of lysozyme (1, 2) and the prophenoloxidase activating sys-
tem (3). These hemocyte-mediated responses are comple-
mented by antibacterial activity, such as lectins, which occur
constitutively in invertebrate hemolymph (4). In addition to
normally occurring factors, several antibacterial peptides are
induced by bacterial infections [namely, the cecropins (4
kDa), attacins (21 to 23 kDa), diptericins (8 kDa), and insect
defensins (4 kDa)] (3, 5).
An important area of invertebrate immunity that has not
been critically addressed concerns how the early responses to
infection are mediated-that is, what is the sequence of
biochemical events operative between microbial invasion
and the appearance of defense mechanisms? To date, only
two early steps in the immune response have been investi-
gated. In one, immune-specific RNA was shown to be
synthesized 2-4 hr after bacterial infection of the moths
Hyalophora cecropia and Galleria mellonella (3). In the
other, inducible lectins were synthesized in the flesh fly
Sarcophaga peregrina almost immediately after their im-
mune system was challenged (6). However, these gene-
specific events follow from earlier steps in transduction of
bacterial invasion signals into physiological defense re-
sponses.
Since many aspects of immunological defense in mammals
are mediated by eicosanoid metabolites of arachidonic acid
(7), we hypothesized that biosynthesis of eicosanoids is also
an essential early step in mediation of the immune response
in invertebrates. We tested this hypothesis by using an insect,
the tobacco hornworm Manduca sexta. We report here that
selective pharmaceutical inhibitors of eicosanoid biosynthe-
sis compromise the hornworm's immune response to bacte-
rial infection. Furthermore, hornworms so compromised
died earlier in the course of infection than did control
animals. These findings indicate that eicosanoid biosynthesis
is a crucial early step in invertebrate immunity.
MATERIALS AND METHODS
Organisms. Larval tobacco hornworms were reared under
standard culture conditions (8), at 280C under a 16-hr light/
8-hr dark photoperiod. Experiments used early fifth (last
prepupal) instar prewandering larvae. The bacterium Serra-
tia marcescens used in this study is a red-pigmented strain
obtained from the culture collection, School of Biological
Sciences at the University of Nebraska-Lincoln. Bacteria
were grown in 50 ml of standard methods broth (Difco) on a
waterbath shaker at 300C and 120 rpm. The cells were used
in midlogarithmic or stationary phase at a titer of 2.5-7.0 x
107 colony-forming units (cfu) per ml.
Bacterial Recovery: Influence of Inhibitors. Test larvae
were injected with either the phospholipase A2 (PLA2) in-
hibitor dexamethasone [(11/3,16a)-9-fluoro-11,17,21-trihy-
droxy-16-methylpregna-1,4-diene-3,20-dione], the cyclooxy-
genase inhibitor indomethacin [1-(p-chlorobenzoyl)-5-
methoxy-2-methyl-3-indolyl-acetic acid], the 5- and 12-
lipoxygenase inhibitor esculetin (6,7-dihydroxycoumarin),
the nonspecific antioxidant maleic acid (cis-butenedioic acid;
Sigma), or a 1:1 combination of indomethacin and esculetin
(all others from BioMol, Plymouth Meeting, PA). All com-
pounds were intrahemocoelically injected into individual
larvae at dosages of 50 ,g per component in 5 ,ul of absolute
ethanol. Injections were made by inserting the needle of a
Hamilton 701 syringe dorsolaterally above the last two spir-
acles, moving the needle into the hemocoel parallel to the
body wall to avoid injuring the alimentary canal, then de-
pressing the plunger. Three to 10 min after injection of
inhibitors, larvae were infected with S. marcescens by intra-
hemocoelic injection of -5 x 105 bacterial cells in 10 ,ul of
broth, on the opposite side in the manner described above.
Control larvae were injected with 5 ,ul of absolute ethanol and
then similarly infected with bacteria. After a 2.5-hr incuba-
tion at 30°C, 100 ,ul of hemolymph was withdrawn from each
Abbreviations: PLA2, phospholipase A2; cfu, colony-forming units;
PI, postinfection; PUFA, polyunsaturated fatty acid.
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insect by excising a proleg and collecting hemolymph in
calibrated microcapillary pipettes. The hemolymph was
placed in 10.0 ml of dilution broth [containing 1 g of tryptone
and 2 g of sodium citrate (pH 7.2) per liter]. Duplicate 0.1-ml
samples of 100- and 1000-fold hemolymph dilutions were
plated on standard methods agar (Difco). The plates were
allowed to dry, inverted, and then incubated at 30'C for 36-40
hr. Red bacterial colonies on each plate were then counted.
In all bacterial recovery experiments, each agar plate repre-
sents a hemolymph sample withdrawn from individually
identifiable larvae.
Control Experiments. Direct effects of the pharmaceutical
inhibitors on bacteria were tested by adding the compounds
to S. marcescens cultures; bacterial growth was unaffected in
all cases. Similarly, injections of the inhibitors into M. sexta
larvae unchallenged with bacteria did not affect subsequent
development. We also considered the possibility that bacteria
that may have leaked onto the outer surface of the larvae
could have increased the apparent recovery of bacterial
colonies after the 2.5-hr incubations. One hour after 105
bacterial cells were painted onto the outer surface of larvae,
no living bacteNa could be recovered, indicating that external
bacteria did not mitigate recovery results. We also assayed
100 l.a of hemolymph from untreated larvae for the presence
of S. marcescens by collecting the hemolymph under sterile
conditions and plating it in duplicate directly onto standard
methods agar. No bacterial colonies were recovered.
Dose-Response Relationship: Bacterial Recovery. Four
groups of seven larvae each were treated with 0, 1.4 x 10-5,
1.4 x 10-3, or 1.4 x 10-1 ;kg of dexamethasone in 5 ul of
ethanol and then infected with bacteria as described above.
After a 1.0-hr incubation at 30'C, 100 jLd of hemolymph was
withdrawn from each insect as described. The hemolymph
was placed in 10.0 ml of dilution broth, and 0.1 ml was plated
in duplicate on standard methods agar. The plates were
incubated, and bacterial colonies were counted as described.
Dose-Response Relationship: Larval Survival. Four groups
of 41 larvae each were injected with either 5 Ml of ethanol or
with 1.4 x 10-5, 1.4 x 10-3, or 1.4 x 10-1 ,Mg of dexametha-
sone in 5 MLI of ethanol. Three to 10 min after injection of
dexamethasone, larvae were infected with -5 x 105 cells of
S. marcescens by intrahemocoelic injection. The larvae were
held at 30'C, and the number of survivors in each group was
counted at 12, 14, 16, 18, and 20 hr postinfection (PI).
Time Course of Bacterial Recovery. Two groups of 27 larvae
each were treated with 5 Ml of ethanol or with 50 MLg of
dexamethasone in S ul ethanol and then infected with S.
marcescens as described above. Small hemolymph samples
(15 Ml) were serially withdrawn from individual larvae at 15,
30, 45, and 60 min PI by clipping the caudal horn. He-
molymph samples were plated, and red-pigmented bacterial
colonies were counted as described.
Arachidonic Acid Rescue. Individuals in groups of 20-41
larvae each were injected with either 5MlI of ethanol, 0.14 Mug
of dexamethasone in 5 Ml of ethanol, or with 0.14 Mg of
dexamethasone in 5 ,ul of ethanol and 50.0 ,g of arachidonic
acid (Sigma) and then infected as described above with
bacteria. The larvae were held at 30'C, and the numbers of
survivors in each group were counted at 2-hr intervals
beginning 12 hr PI.
Statistical analyses on detectable S. marcescens colonies
in the larval hemolymph were conducted by using the
Wilcoxon two-sample rank test or the Kruskal-Wallis statis-
tics, and survivorship data were analyzed by the R x C
contingency test.
Determination of Polyunsaturated Fatty Acids (PUFAs).
Total lipids were extracted from hemolymph and fat bodies
from five fifth-instar larvae by the method of Bligh and Dyer
(9). Phospholipids were isolated by thin-layer chromatogra-
phy of total lipid extract (10). Purified phospholipids were
transmethylated by refluxing in acidified methanol for 1 hr at
850C (11). The resulting fatty acid methyl esters were ana-
lyzed by gas chromatography and mass spectrometry (11).
Eicosanoid Biosynthesis. Fifth-instar M. sexta larvae were
injected with 9.25 x 105 Bq of tritiated arachidonic acid
([5,6,8,9,11,12,14,15-3H]20:4; 2.22-3.70 TBq/mmol; New
England Nuclear). After 1 min, 100 Ml of hemolymph was
collected as described above. Eicosanoids were extracted
three times with acidified ethyl acetate and then separated by
thin-layer chromatography (12). Fractions were identified by
cochromatography with authentic unlabeled standards, and
radioactivity in each fraction was assayed by liquid scintil-
lation counting on a LKB-Wallac 1219 Rackbeta counter at
66% counting efficiency.
RESULTS
Time Course of Bacterial Recovery. Fig. 1 shows that the
median bacterial recovery from ethanol-treated control lar-
vae was below the limits of detectability for the first hour PI
(<103 cfu per ml of hemolymph; n = 27 for all time points),
indicating that the larvae are able to remove injected bacteria
from their hemolymph. In contrast, the dexamethasone-
treated larvae yielded a median value of 1.8 x 104 cfu per ml
of hemolymph at 15 min PI (different from controls, H =
10.90), which steadily increased to 2.3 x 104, 3.3 x 104, and
4.6 x 104 cfu per ml of hemolymph at 30 min (H = 5.52), 45
min (H = 7.68), and 60 min (H = 11.94) PI, respectively (Fig.
1; n = 27 for all points, except n = 26 at 60 min). Presumably
this increase reflects bacterial growth in the hemolymph of
immunocompromised larvae.
Bacterial Recovery: Influence of Inhibitors. The results of
the bacterial recovery experiments are summarized in Fig. 2.
Bacteria were recovered from significantly more larvae
treated with eicosanoid biosynthesis inhibitors than from
control larvae. Red-pigmented S. marcescens bacterial col-
onies were seen on 87% of the agar plates from dexametha-
sone-treated larvae, whereas only 21% of the plates from
control larvae had visible colonies (W = 361.5, P = 0.0007).
Fig. 2 shows that larvae treated with compounds that block
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FIG. 1. Time course of recovery of the bacterial pathogen S.
marcescens from larvae of M. sexta. Test larvae (+) were first
injected with dexamethasone, and control larvae (o) were first
injected with ethanol. Both groups of larvae were then intrahemo-
coelically infected with -5 x 105 bacterial cells 3-10 min after
treatment. At 15-min intervals PI, 15-Al hemolymph samples were
serially withdrawn from the caudal horn, diluted, and plated on
standard methods agar plates.
Proc. Natl. Acad Sci. USA 88 (1991) 1065






























FIG. 2. Effect of treatment with eicosanoid biosynthesis inhibi-
tors on immune response of M. sexta larvae to infection with the
bacterial pathogen S. marcescens. Test larvae were first injected
with dexamethasone (DEX), indomethacin (INDO), ecsuletin (ESC),
maleic acid (MAL), or a 1:1 combination of esculetin and indometh-
acin (ESC + INDO). Control larvae were first injected with absolute
ethanol (EtOH) only. Both test and control larvae were intrahemo-
coelically infected with - 5 x 105 bacterial cells 3-10 min after
treatment. After a 2.5-hr incubation, 100-pl hemolymph samples
were withdrawn, serially diluted, then plated on standard methods
agar plates. The number of individual larvae per treatment is given
above each treatment bar; the height of histogram bars represents the
proportion of larvae from which bacteria were recovered, and the
error bars represent 1 SE of the mean.
yielded intermediate results: colonies were recovered from
about 58% of esculetin-treated larvae (W = 409.5, P = 0.0433)
and from 55% of indomethacin-treated larvae (W = 424.0, P
= 0.0624). When both major pathways were inhibited simul-
taneously with indomethacin and esculetin, bacterial colo-
nies were recovered from 86% of the larvae, which is nearly
identical to the dexamethasone effect (W = 359.0, P =
0.0010). Experiments with the nonspecific antioxidant com-
pound maleic acid, which does not inhibit PUFA oxygenation
pathways, yielded results identical to those of control larvae
(W = 450.0, P = 0.8536).
Dose-Response for Dexamethasone: Bacterial Recovery.
Dexamethasone treatments compromised the ability of horn-
worm larvae to clear S. marcescens from hemolymph sam-
ples taken at 1 hr after infection. Fig. 3 shows that increased
dexamethasone dosages were associated with increased re-
covery of red-pigmented bacterial colonies. Hemolymph
samples from larvae treated with ethanol or with 1.4 x 10-5,
1.4 x 10-3, or 1.4 x 10-1 ,g of dexamethasone per larvae
yielded median values of 0.35 x 104, 0.55 x 104 (not signif-
icant, H = 0.722), 8.2 x 104 (borderline significance, H =
3.756), and 10.1 x 104 (significant, H = 5.409) cfu per ml of
hemolymph, respectively. Other experiments with higher
dosages of dexamethasone (0.5 and 50.0 ,ug per larvae) did
not further increase recovery of bacterial colonies.
Dose-Response for Dexamethasone: Larval Survival. The
strain of S. marcescens used in our experiments is pathogenic
to M. sexta larvae: intrahemocoelic injection of -300 bac-
terial cells led to death within 24 hr. Since dexamethasone
and the other inhibitors of eicosanoid biosynthesis compro-
mised the ability of the larvae to clear bacteria from circu-
lation, we expected similar treatments would also result in
reduced survivorship during the first 24 hr PI. At 14 hr PI,
46.3% of the ethanol-treated control larvae were still alive.
However (Fig. 4), only 9.8%, 24.4%, and 43.9% of larvae
treated with 1.4 x 10-1, 1.4 x 10', or 1.4 x 10-5 ,g of
dexamethasone per larvae survived 14 hr [G(Yates) values
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FIG. 3. Dose-response for dexamethasone: bacterial recovery.
M. sexta larvae were first injected with 0.0-0.14 gg of dexametha-
sone and then intrahemocoelically infected with 6 x 105 cells of the
bacterium S. marcescens. After 1 hr at 30'C, hemolymph samples
were withdrawn, diluted, and plated on standard methods agar
plates. Red-pigmented bacterial colonies were counted 40-48 hr
later. Columns with the same letters are not significantly different
from each other (Kruskal-Wallis statistics).
The larval deaths could, of course, have been due to toxic
effects of dexamethasone. We eliminated this possibility with
a series of experiments by injecting unchallenged larvae with
large doses (50 ,ug) of dexamethasone, ethanol (the dexa-
methasone vehicle), the cell-free bacterial culture broth, and
arachidonic acid. In all cases the larvae did not die during the
24-hr experimental period and showed no observable behav-
ioral effects. These findings indicate that reduced ability to
clear bacteria from hemolymph is associated with their earlier
death from pathogenic infections.
Arachidonic Acid Reversed the Dexamethasone Effects. As
we have just seen, dexamethasone greatly reduced the pro-
portion of larvae that survived S. marcescens infections (Fig.













FIG. 4. Dose-response for dexamethasone (DEX): larval sur-
vival. M. sexta larvae were injected with 0.0-0.14 ,g of dexametha-
sone or with 0.14 gg of dexamethasone plus 50 jig of arachidonic acid(ARAC) and then intrahemocoelically infected with 6 x 105 cells of
the bacterium S. marcescens. After 14 hr at 30°C, surviving larvae
were counted. Bars with the same letter are not significantly different
from each other (R x C contingency test).
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treatment with arachidonic acid. At 14 hr PI, 45% of larvae
treated with both dexamethasone and 50.0 ,ug of arachidonic
acid were alive, compared to 46.3% of ethanol-treated con-
trols [G(Yates) = 0.03] and to 9.8% of larvae treated with 0.14
,ug of dexamethasone alone [G(Yates) = 7.56].
PUFA Composition. Analysis of fatty acid compositions of
phospholipids purified from hemolymph showed that all three
eicosanoid precursor PUFAs were present in M. sexta. These
three components accounted for about 1% of total phospho-
lipid fatty acids, comparable to results from many other
terrestrial insect species (10); of these precursorPUFAs, 20:3
(n - 6) made up 20%, 20:4 (n - 6) made up 34%, and 20:5 (n
- 3) made up 46%. Retention times and mass spectra of these
compounds were exactly congruent with authentic stan-
dards. Thus, all potential eicosanoid precursors were present
in this insect in sufficient quantities to support eicosanoid
biosynthesis.
Eicosanoid Biosynthesis from Arachidonic Acid. Larvae of
M. sexta were able to convert radioactive arachidonic acid
into eicosanoids. One minute after injection, 100-,ul he-
molymph samples were withdrawn from each of seven lar-
vae. In these samples, 5.3% of the injected radioactivity
(mean = 2.9 x 105 dpm) was recovered. Most (95-97%) of the
recovered radioactivity was arachidonic acid. Three frac-
tions (expressed as the percentage of recovered radioactivity
+ 1 SD, n = 7) had chromatographic behavior identical to the
prostaglandins F2, (0.1% + 0.01%), E2 (0.1% ± 0.02%), and
D2 (0.5% ± 0.2%). A similar amount of radioactivity was also
recovered in an otherwise uncharacterized fraction in the
same Rf range reported for lipoxygenase metabolites in
mammalian systems, presumably hydroxyeicosatetraenoic
acids (12).
DISCUSSION
In vertebrates and invertebrates, eicosanoids are formed
from unesterified C20 PUFAs, which arise primarily by action
of PLA2 on phospholipid components of membranes (13).
Once available, these PUFAs can be oxygenated by two main
routes: the cyclooxygenase pathway, which leads to the
biologically active prostaglandins, and the lipoxygenase
pathway, which is a complex of pathways leading to hydro-
peroxyeicosatetraenoic acids, hydroxyeicosatetraenoic ac-
ids, leukotrienes, lipoxins, and hepoxilins (13, 14). Products
of both pathways are important in various aspects of mam-
malian host defense. For example, cyclooxygenase products
have profound effects on macrophage locomotion, shape
changes, and phagocytosis (15), whereas lipoxygenase prod-
ucts mediate chemotaxis, chemokinesis, and adherence re-
sponses of neutrophils (7).
The results presented in this paper strongly support our
hypothesis that eicosanoids also mediate invertebrate im-
mune responses. This view is summarized in the following
arguments. First, inhibition of eicosanoid formation with
specific inhibitors of PLA2, cyclooxygenase, and lipoxyge-
nase significantly reduced the ability of larvae to clear
pathogenic bacteria from their hemolymph. Second, the
reduced capability to clear bacteria was associated with
increased mortality caused by these bacteria. Third, for
dexamethasone, both the increased bacterial recovery and
decreased larval survival were expressed in a dose-
dependent manner. Finally, the dexamethasone effects were
reversed by treatment with arachidonic acid.
A major difficulty with using pharmaceutical inhibitors to
probe biochemical pathways is the possibility of nonspecific
or nonphysiological effects. The inhibitors used here are
known to be very specific in mammals; less is known about
their specificity in invertebrate systems. We feel the extrap-
olation to M. sexta is justified by four examples where these
compounds have been shown to have similar pharmacolog-
ical action in invertebrates and mammals. First, acetylsali-
cylic acid (aspirin) inhibits prostaglandin biosynthesis in
microsomal preparations from cockroach fat body (16), in in
vitro preparations from house flies (17), and in reproductive
tissues of the cricket Teleogryllus commodus (18). Second,
indomethacin inhibits prostaglandin-mediated oviposition
behavior in silk moths (19). Third, the PLA2 inhibitor dex-
amethasone mimics the effects of essential arachidonic acid
deficiency in the mosquito Culex pipiens (20). Fourth, escu-
letin inhibits eicosanoid-mediated host penetration behavior
of the blood fluke Schistosoma mansoni (21). Finally, the
possibility of nonspecific effects was assessed by our use of
high doses of maleic acid, a general antioxidant that does not
interfere with cyclooxygenase or lipoxygenase enzymes. In
these experiments, bacterial recoveries from larvae treated
with maleic acid were exactly congruent with control larvae.
Dose-response relationships and end-product reversal
provide crucial indications that inhibitors of eicosanoid bio-
synthesis interrupt a physiological link in invertebrate im-
mune response to bacterial infections. Significantly fewer
bacterial colonies were recovered from larvae that received
no dexamethasone or very low doses of dexamethasone
compared to larvae that were treated with higher doses. An
analogous dose-response relationship was also observed in
the survivorship experiments. Dexamethasone exerts its
effects by inhibiting PLA2, which indirectly inhibits ei-
cosanoid biosynthesis because substrate (i.e., unesterified
arachidonic acid) is not available. Ifdexamethasone inhibited
PLA2 in M. sexta, then treatment with arachidonic acid could
be expected to ameliorate the effects on survivorship of
infected larvae. Indeed, arachidonic acid treatment signifi-
cantly reduced mortality to the level observed in ethanol-
injected control larvae. These experiments support the idea
that dexamethasone interrupts eicosanoid mediation of im-
mune response in M. sexta.
The presence and biological significance of PUFAs and
eicosanoids in insects are not yet widely appreciated (10, 13,
22). For this reason, when invoking eicosanoid mediation of
an important physiological response in an invertebrate not
yet studied in this regard, such as M. sexta, it is necessary to
demonstrate that both substrate and eicosanoid biosynthetic
activity are present. So far, there is only one other well-
documented physiological role of eicosanoids in insects-
namely release of egg-laying behavior in three species (23).
Capillary column gas chromatography and mass spectromet-
ric analysis confirmed the presence of all three known
eicosanoid precursor PUFAs, 20:3 (n - 6), 20:4 (n - 6), and
20:5 (n - 3), in phospholipids from hemolymph of M. sexta.
We also observed biosynthesis of eicosanoids from radioac-
tive precursor in M. sexta hemolymph. This evidence shows
that M. sexta is competent to biosynthesize eicosanoids from
arachidonic acid. It is expected that a wide range of ei-
cosanoid species will prove to be components of a complex
regulatory system that initiates and terminates many ele-
ments of the immunological response in invertebrates, as
seen in mammals (7).
Although we do not yet know the precise functions ei-
cosanoids play in insect immunity, the timing of their action
provides some insight. Our time course experiments show
that the dexamethasone effect on clearing S. marcescens
from hemolymph can be seen as early as 15 min PI. Rapid
clearance of another insect pathogenic bacterium, Pseudom-
onas aeruginosa P11-1, from the hemolymph of M. sexta
larvae has been described by Dunn and colleagues. This
clearance was attributed to nodule formation at or near the
injection site during the first 2 hr PI (24), followed by
phagocytosis in the next 6 hr (25). They correlated these
observations with hemocyte population dynamics during the
first hour PI (26, 27). We suggest that eicosanoid metabolism
mediates some/all of these early defense responses.
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